ArticlePsychiatry and clinical psychopharmacology2025
Relationship Between Illness Duration and Social Cognitive Abilities in Schizophrenia Spectrum Disorder.
Article in Psychiatry and clinical psychopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Social cognition can be defined as the ability to perceive and interpret others' thoughts, intentions, and behaviors. It is known that there are deficiencies in social cognitive skills in schizophrenia. This study aims to evaluate the social cognitive skills of schizophrenia spectrum disorder patients from the very early stages using theory of mind and emotion identification/discrimination tests and to examine the changes in these skills during schizophrenia. Methods: Seventy-nine patients who met the schizophrenia criteria according to Diagnostic and Statistical Manual of Mental Disorders-5 , except for duration, and were diagnosed with schizophrenia were divided into 3 groups according to the duration of illness: less than 6 months (n = 18), 6-24 months (n= 35), and more than 24 months (n = 26). The participants were administered the Positive and Negative Syndrome Scale (PANSS), the Global Assessment of Functioning Scale (GAF), the Reading the Mind in the Eyes Test (RMET), and the Facial Identification and Discrimination Tests (FEIT and FEDT), and the test scores were compared between the 3 groups. Results: There was no significant difference between the groups regarding PANSS, GAF and RMET, FEIT, and FEDT scores (P > .05). There was also no significant relationship between the illness duration and RMET, FEIT, and FEDT scores (P > .05). Conclusion: There was no significant relationship between disease duration and social cognitive skills in schizophrenia spectrum disorder patients. This finding suggests that social cognitive deficits may be a trait marker of schizophrenia.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.